Keloid remodeling: improved outcomes with fractional CO2 laser plus intralesional triamcinolone in a Fitzpatrick IV patient.

Keloid scarring is more prevalent in individuals with pigmented skin and can be particularly challenging to treat due to the risk of dyspigmentation and limited response to first-line therapies. This case describes a Fitzpatrick type IV patient whose keloid remodeling plateaued with intralesional corticosteroids but improved significantly following adjunctive fractional CO2 laser therapy. The report highlights the safe use of lasers in darker skin types and reinforces the need to expand equitable access to such treatment modalities.